The highest estimate is 45.00. From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LBRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
The current price of LBRX is $30.00 USD — it has decreased by -0.17% in the past 24 hours. Watch LB Pharmaceuticals stock price performance more closely on the chart.
What is LB Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LB Pharmaceuticals stocks are traded under the ticker LBRX.
When is the next LB Pharmaceuticals earnings date?▼
LB Pharmaceuticals is going to release the next earnings report on September 02, 2026.
What were LB Pharmaceuticals earnings last quarter?▼
LBRX earnings for the last quarter are -0.67 USD per share, whereas the estimation was -0.75 USD resulting in a +10.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LB Pharmaceuticals revenue for the last year?▼
LB Pharmaceuticals revenue for the last year amounts to 0 USD.
What is LB Pharmaceuticals net income for the last year?▼
LBRX net income for the last year is -126.2M USD.
How many employees does LB Pharmaceuticals have?▼
As of June 20, 2026, the company has 16 employees.
In which sector is LB Pharmaceuticals located?▼
LB Pharmaceuticals operates in the Health & Wellness sector.
When did LB Pharmaceuticals complete a stock split?▼
LB Pharmaceuticals has not had any recent stock splits.
Where is LB Pharmaceuticals headquartered?▼
LB Pharmaceuticals is headquartered in New York, United States.